Skip to ContentSkip to Navigation
Over ons Praktische zaken Waar vindt u ons prof. dr. R.A. (Robert) Schoevers

Publicaties

Assessment of biomarker stability and assay performance parameters for medical diagnosis: a case study of diagnosis of major depressive disorder

Attitudes and Perceptions of Mental Healthcare Recipients and their Close Ones on Psychedelic Treatments: results from a Dutch Mixed Methods Survey

Change in brain activation after transcranial pulsed electromagnetic fields in treatment-resistant depression

Circadian markers as a predictor of response in the treatment of depression: A systematic review

High-Dose Methylphenidate and Carboxylesterase 1 Genetic Variability in Patients With Attention-Deficit/Hyperactivity Disorder: A Case Series

Identifying predictors of a favourable outcome for outpatients with a persistent depressive disorder treated with Cognitive Behavioural Analysis System of Psychotherapy: A prospective cohort study

Naschokken; over de psychische gevolgen van de gaswinning in Groningen

Oral esketamine in patients with treatment-resistant depression: a double-blind, randomized, placebo-controlled trial with open-label extension

Patient perspectives and experiences with psilocybin treatment for treatment-resistant depression: a qualitative study

Predicting Psychiatric Care Intensity with Pre-Intake Data

Lees meer

Pers/media

Wat hebben ketamine en depressie met elkaar te maken?

Trippend in de scanner: psilocybine heeft wekenlang effect op brein

EU financiert baanbrekend onderzoek naar therapie met psychedelica

EU maakt miljoenen vrij voor studie naar psilocybine

EU funds first psychedelic study, in patients with incurable diseases

Hoe help je iemand die depressief is?

Medische Publieksacademie UMCG

Ketamine: partydrug of hét redmiddel voor ernstige psychiatrische stoornissen?

Kamerbrief over therapeutische toepassing van psychedelica

Lees meer